Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain | 74 | 2023 | 1689 | 8.290 |
Why?
|
Magnetic Resonance Imaging | 64 | 2023 | 1221 | 6.370 |
Why?
|
Brain Mapping | 25 | 2022 | 195 | 5.370 |
Why?
|
Diffusion Magnetic Resonance Imaging | 17 | 2022 | 96 | 4.680 |
Why?
|
White Matter | 21 | 2023 | 149 | 4.530 |
Why?
|
Image Processing, Computer-Assisted | 19 | 2023 | 219 | 4.180 |
Why?
|
Cognitive Dysfunction | 32 | 2023 | 938 | 3.990 |
Why?
|
Alzheimer Disease | 38 | 2023 | 1942 | 3.580 |
Why?
|
Diffusion Tensor Imaging | 11 | 2023 | 81 | 3.110 |
Why?
|
Aging | 33 | 2023 | 1593 | 2.810 |
Why?
|
Image Interpretation, Computer-Assisted | 10 | 2017 | 81 | 2.590 |
Why?
|
Cognition | 28 | 2023 | 1277 | 2.270 |
Why?
|
Nervous System Diseases | 3 | 2022 | 145 | 2.040 |
Why?
|
Aged | 66 | 2023 | 9448 | 1.970 |
Why?
|
Aged, 80 and over | 57 | 2023 | 4851 | 1.960 |
Why?
|
Neuroimaging | 12 | 2023 | 136 | 1.890 |
Why?
|
Humans | 121 | 2023 | 29337 | 1.820 |
Why?
|
Hippocampus | 14 | 2022 | 274 | 1.710 |
Why?
|
Neural Pathways | 11 | 2020 | 83 | 1.550 |
Why?
|
TDP-43 Proteinopathies | 6 | 2022 | 104 | 1.470 |
Why?
|
Image Enhancement | 8 | 2013 | 57 | 1.450 |
Why?
|
Male | 73 | 2023 | 15621 | 1.450 |
Why?
|
Female | 71 | 2023 | 16197 | 1.410 |
Why?
|
Algorithms | 9 | 2014 | 400 | 1.350 |
Why?
|
Artifacts | 11 | 2023 | 32 | 1.290 |
Why?
|
Cerebral Amyloid Angiopathy | 5 | 2023 | 115 | 1.270 |
Why?
|
DNA-Binding Proteins | 7 | 2022 | 254 | 1.240 |
Why?
|
Arteriolosclerosis | 4 | 2023 | 71 | 1.240 |
Why?
|
Organ Size | 10 | 2019 | 107 | 1.150 |
Why?
|
Independent Living | 6 | 2022 | 281 | 1.100 |
Why?
|
Cohort Studies | 21 | 2023 | 1939 | 0.990 |
Why?
|
Imaging, Three-Dimensional | 5 | 2016 | 222 | 0.980 |
Why?
|
Gray Matter | 7 | 2020 | 56 | 0.880 |
Why?
|
Nerve Fibers, Myelinated | 5 | 2011 | 39 | 0.840 |
Why?
|
Neuropsychological Tests | 18 | 2022 | 1251 | 0.820 |
Why?
|
Overweight | 1 | 2021 | 65 | 0.780 |
Why?
|
Connectome | 1 | 2020 | 14 | 0.770 |
Why?
|
Cerebrovascular Disorders | 4 | 2022 | 132 | 0.740 |
Why?
|
Reproducibility of Results | 10 | 2023 | 788 | 0.740 |
Why?
|
Cerebrovascular Circulation | 4 | 2022 | 43 | 0.710 |
Why?
|
Cognitive Aging | 2 | 2021 | 81 | 0.710 |
Why?
|
Amygdala | 1 | 2019 | 50 | 0.670 |
Why?
|
Adult | 21 | 2023 | 8601 | 0.650 |
Why?
|
Anisotropy | 9 | 2023 | 58 | 0.640 |
Why?
|
Cerebral Small Vessel Diseases | 3 | 2022 | 12 | 0.620 |
Why?
|
Cognition Disorders | 9 | 2023 | 1011 | 0.610 |
Why?
|
Autopsy | 9 | 2021 | 335 | 0.610 |
Why?
|
Longitudinal Studies | 9 | 2021 | 1442 | 0.590 |
Why?
|
Frontal Lobe | 4 | 2019 | 81 | 0.590 |
Why?
|
Genome-Wide Association Study | 8 | 2019 | 301 | 0.590 |
Why?
|
Young Adult | 8 | 2020 | 1932 | 0.540 |
Why?
|
Atrophy | 4 | 2021 | 102 | 0.530 |
Why?
|
Sensitivity and Specificity | 9 | 2023 | 553 | 0.500 |
Why?
|
Cerebral Cortex | 4 | 2022 | 195 | 0.500 |
Why?
|
Postmortem Changes | 2 | 2016 | 34 | 0.490 |
Why?
|
Cerebral Infarction | 4 | 2020 | 152 | 0.480 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2013 | 26 | 0.460 |
Why?
|
Dementia | 5 | 2023 | 521 | 0.450 |
Why?
|
Nerve Fibers | 2 | 2014 | 14 | 0.420 |
Why?
|
Neurodegenerative Diseases | 3 | 2021 | 117 | 0.420 |
Why?
|
Diet, Mediterranean | 2 | 2023 | 62 | 0.400 |
Why?
|
Memory | 6 | 2021 | 318 | 0.400 |
Why?
|
Reference Values | 6 | 2013 | 227 | 0.390 |
Why?
|
Fourier Analysis | 1 | 2010 | 8 | 0.380 |
Why?
|
Models, Anatomic | 1 | 2010 | 52 | 0.380 |
Why?
|
Genetic Variation | 3 | 2019 | 105 | 0.380 |
Why?
|
Biomarkers | 7 | 2023 | 689 | 0.350 |
Why?
|
Formaldehyde | 1 | 2009 | 14 | 0.350 |
Why?
|
Limbic System | 1 | 2009 | 11 | 0.350 |
Why?
|
Phobic Disorders | 1 | 2009 | 62 | 0.340 |
Why?
|
Information Storage and Retrieval | 1 | 2008 | 5 | 0.330 |
Why?
|
Intracranial Arteriosclerosis | 2 | 2020 | 51 | 0.330 |
Why?
|
Pulse | 1 | 2008 | 6 | 0.330 |
Why?
|
Temporal Lobe | 5 | 2020 | 105 | 0.320 |
Why?
|
Atlases as Topic | 2 | 2020 | 7 | 0.320 |
Why?
|
Myocardial Contraction | 1 | 2008 | 75 | 0.320 |
Why?
|
Neuropathology | 4 | 2021 | 79 | 0.300 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2017 | 306 | 0.300 |
Why?
|
Antibodies, Antiphospholipid | 2 | 2019 | 26 | 0.280 |
Why?
|
Diffuse Axonal Injury | 2 | 2004 | 3 | 0.280 |
Why?
|
Exercise | 2 | 2021 | 468 | 0.280 |
Why?
|
Axons | 2 | 2004 | 38 | 0.280 |
Why?
|
Positron-Emission Tomography | 2 | 2023 | 88 | 0.270 |
Why?
|
Genetic Loci | 4 | 2019 | 61 | 0.270 |
Why?
|
Frontotemporal Dementia | 2 | 2022 | 14 | 0.270 |
Why?
|
Linear Models | 5 | 2019 | 254 | 0.260 |
Why?
|
Cerebral Hemorrhage | 2 | 2023 | 129 | 0.260 |
Why?
|
tau Proteins | 3 | 2023 | 202 | 0.260 |
Why?
|
Memory, Episodic | 2 | 2019 | 116 | 0.250 |
Why?
|
Brain Neoplasms | 1 | 2006 | 124 | 0.250 |
Why?
|
Prefrontal Cortex | 3 | 2016 | 152 | 0.250 |
Why?
|
Middle Aged | 13 | 2021 | 9823 | 0.250 |
Why?
|
Neuropeptides | 3 | 2020 | 29 | 0.240 |
Why?
|
Amyloid beta-Peptides | 3 | 2023 | 294 | 0.240 |
Why?
|
Tauopathies | 1 | 2023 | 17 | 0.240 |
Why?
|
Brain Diseases | 2 | 2021 | 82 | 0.230 |
Why?
|
Phantoms, Imaging | 4 | 2010 | 42 | 0.230 |
Why?
|
DNA Methylation | 3 | 2019 | 124 | 0.220 |
Why?
|
Lewy Bodies | 2 | 2021 | 195 | 0.220 |
Why?
|
Dementia, Vascular | 1 | 2023 | 41 | 0.220 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2022 | 22 | 0.220 |
Why?
|
Nerve Tissue Proteins | 3 | 2020 | 173 | 0.220 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 959 | 0.220 |
Why?
|
Cerebral Arterial Diseases | 1 | 2021 | 7 | 0.210 |
Why?
|
Health Literacy | 1 | 2023 | 102 | 0.210 |
Why?
|
Dietary Supplements | 1 | 2021 | 53 | 0.200 |
Why?
|
Vitamin D | 1 | 2021 | 31 | 0.200 |
Why?
|
Proteomics | 1 | 2022 | 91 | 0.200 |
Why?
|
Inflammation | 2 | 2016 | 344 | 0.200 |
Why?
|
Dietary Approaches To Stop Hypertension | 1 | 2021 | 20 | 0.190 |
Why?
|
Disease Progression | 2 | 2021 | 787 | 0.190 |
Why?
|
Gene Expression | 2 | 2019 | 226 | 0.190 |
Why?
|
Proteins | 1 | 2020 | 72 | 0.190 |
Why?
|
Stroke | 2 | 2016 | 293 | 0.190 |
Why?
|
Amyloid Neuropathies | 1 | 2020 | 4 | 0.190 |
Why?
|
Diabetes Complications | 1 | 2020 | 64 | 0.180 |
Why?
|
Neurologic Examination | 1 | 2020 | 146 | 0.180 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 18 | 0.180 |
Why?
|
Psychomotor Performance | 2 | 2020 | 216 | 0.180 |
Why?
|
Adaptation, Psychological | 1 | 2020 | 143 | 0.180 |
Why?
|
Occipital Lobe | 1 | 2019 | 13 | 0.180 |
Why?
|
Parietal Lobe | 1 | 2019 | 21 | 0.180 |
Why?
|
Adenylate Kinase | 1 | 2019 | 7 | 0.180 |
Why?
|
Cost of Illness | 1 | 2020 | 54 | 0.180 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2019 | 19 | 0.180 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 14 | 0.180 |
Why?
|
Neurodevelopmental Disorders | 1 | 2019 | 20 | 0.180 |
Why?
|
Hypertension | 1 | 2022 | 266 | 0.180 |
Why?
|
Motor Skills | 2 | 2021 | 61 | 0.180 |
Why?
|
Neural Stem Cells | 1 | 2019 | 14 | 0.180 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 59 | 0.180 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 27 | 0.170 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 402 | 0.170 |
Why?
|
Genetic Association Studies | 1 | 2019 | 86 | 0.170 |
Why?
|
Age Factors | 3 | 2016 | 843 | 0.170 |
Why?
|
Motor Disorders | 1 | 2019 | 22 | 0.170 |
Why?
|
Frontotemporal Lobar Degeneration | 1 | 2019 | 28 | 0.170 |
Why?
|
Lateral Ventricles | 1 | 2018 | 7 | 0.170 |
Why?
|
Transcriptome | 1 | 2019 | 83 | 0.170 |
Why?
|
Parkinsonian Disorders | 1 | 2021 | 217 | 0.160 |
Why?
|
Genome, Human | 1 | 2018 | 49 | 0.160 |
Why?
|
Olfaction Disorders | 1 | 2019 | 53 | 0.160 |
Why?
|
Datasets as Topic | 1 | 2018 | 4 | 0.160 |
Why?
|
Health Behavior | 1 | 2019 | 159 | 0.160 |
Why?
|
Delay Discounting | 1 | 2018 | 24 | 0.160 |
Why?
|
Kidney | 1 | 2019 | 173 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 441 | 0.150 |
Why?
|
Microfilament Proteins | 1 | 2017 | 22 | 0.150 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 50 | 0.150 |
Why?
|
Brain Infarction | 1 | 2017 | 74 | 0.150 |
Why?
|
Adolescent | 3 | 2018 | 2279 | 0.150 |
Why?
|
RNA, Messenger | 1 | 2017 | 323 | 0.150 |
Why?
|
Nuclear Proteins | 1 | 2017 | 88 | 0.150 |
Why?
|
Perforant Pathway | 1 | 2016 | 5 | 0.140 |
Why?
|
Disruptive, Impulse Control, and Conduct Disorders | 1 | 2016 | 10 | 0.140 |
Why?
|
Computer Simulation | 2 | 2008 | 218 | 0.140 |
Why?
|
Intelligence | 1 | 2016 | 25 | 0.140 |
Why?
|
Neurons | 1 | 2019 | 374 | 0.140 |
Why?
|
Economics | 1 | 2016 | 18 | 0.140 |
Why?
|
Comprehension | 1 | 2016 | 28 | 0.140 |
Why?
|
Membrane Proteins | 1 | 2017 | 173 | 0.140 |
Why?
|
Neocortex | 1 | 2016 | 34 | 0.140 |
Why?
|
Pyramidal Tracts | 2 | 2014 | 4 | 0.140 |
Why?
|
Corpus Callosum | 2 | 2014 | 15 | 0.140 |
Why?
|
Dominance, Cerebral | 2 | 2013 | 23 | 0.130 |
Why?
|
Sleep Deprivation | 1 | 2016 | 63 | 0.130 |
Why?
|
Microglia | 1 | 2016 | 124 | 0.130 |
Why?
|
Time Factors | 4 | 2019 | 1616 | 0.130 |
Why?
|
Gyrus Cinguli | 1 | 2014 | 22 | 0.120 |
Why?
|
Financial Management | 1 | 2014 | 24 | 0.120 |
Why?
|
Nerve Net | 3 | 2019 | 54 | 0.120 |
Why?
|
Cerebellum | 1 | 2013 | 57 | 0.120 |
Why?
|
Reward | 1 | 2013 | 34 | 0.120 |
Why?
|
Choice Behavior | 1 | 2013 | 56 | 0.110 |
Why?
|
Risk Factors | 4 | 2022 | 2443 | 0.110 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2016 | 343 | 0.110 |
Why?
|
Epidemiologic Research Design | 1 | 2012 | 16 | 0.110 |
Why?
|
In Vitro Techniques | 1 | 2013 | 213 | 0.110 |
Why?
|
Musculoskeletal Pain | 1 | 2012 | 20 | 0.110 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2012 | 5 | 0.110 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2012 | 38 | 0.110 |
Why?
|
Diffusion | 2 | 2002 | 28 | 0.110 |
Why?
|
Databases, Factual | 1 | 2014 | 330 | 0.110 |
Why?
|
Motor Activity | 1 | 2015 | 369 | 0.100 |
Why?
|
Cadaver | 1 | 2013 | 359 | 0.100 |
Why?
|
Risk-Taking | 1 | 2011 | 32 | 0.100 |
Why?
|
United States | 2 | 2021 | 2333 | 0.100 |
Why?
|
Chronic Pain | 1 | 2012 | 112 | 0.100 |
Why?
|
Movement Disorders | 1 | 2012 | 141 | 0.100 |
Why?
|
Motion | 1 | 2009 | 24 | 0.090 |
Why?
|
Fixatives | 1 | 2009 | 7 | 0.090 |
Why?
|
Sclerosis | 2 | 2019 | 68 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 2 | 2019 | 21 | 0.080 |
Why?
|
Self Report | 2 | 2021 | 218 | 0.080 |
Why?
|
Evoked Potentials | 1 | 2007 | 18 | 0.080 |
Why?
|
Probability | 2 | 2021 | 94 | 0.080 |
Why?
|
Case-Control Studies | 1 | 2009 | 638 | 0.080 |
Why?
|
Prospective Studies | 2 | 2023 | 1811 | 0.080 |
Why?
|
Genotype | 2 | 2019 | 405 | 0.070 |
Why?
|
Radiography | 1 | 2009 | 678 | 0.070 |
Why?
|
Phenotype | 2 | 2019 | 355 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2006 | 91 | 0.070 |
Why?
|
Software | 1 | 2005 | 72 | 0.070 |
Why?
|
Alleles | 2 | 2017 | 224 | 0.070 |
Why?
|
Actigraphy | 2 | 2016 | 98 | 0.070 |
Why?
|
Preoperative Care | 1 | 2006 | 135 | 0.070 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2004 | 10 | 0.060 |
Why?
|
Neurosurgical Procedures | 1 | 2006 | 150 | 0.060 |
Why?
|
Diet, Sodium-Restricted | 1 | 2023 | 6 | 0.060 |
Why?
|
Caloric Restriction | 1 | 2023 | 11 | 0.060 |
Why?
|
Brain Edema | 1 | 2003 | 22 | 0.060 |
Why?
|
Brain Injuries | 1 | 2003 | 47 | 0.060 |
Why?
|
Triglycerides | 1 | 2022 | 41 | 0.060 |
Why?
|
Acculturation | 1 | 2023 | 33 | 0.060 |
Why?
|
Cholesterol | 1 | 2022 | 50 | 0.050 |
Why?
|
Qualitative Research | 1 | 2023 | 112 | 0.050 |
Why?
|
Internal Capsule | 1 | 2002 | 1 | 0.050 |
Why?
|
Depression | 2 | 2017 | 465 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2022 | 17 | 0.050 |
Why?
|
Motivation | 1 | 2023 | 100 | 0.050 |
Why?
|
Spinal Cord | 1 | 2022 | 103 | 0.050 |
Why?
|
Arousal | 1 | 2001 | 42 | 0.050 |
Why?
|
Reaction Time | 1 | 2021 | 123 | 0.050 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 16 | 0.050 |
Why?
|
Oxygen | 2 | 2011 | 85 | 0.050 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2020 | 5 | 0.050 |
Why?
|
Actinin | 1 | 2020 | 7 | 0.050 |
Why?
|
Angiography | 1 | 2021 | 38 | 0.050 |
Why?
|
Vesicular Transport Proteins | 1 | 2020 | 9 | 0.050 |
Why?
|
ROC Curve | 2 | 2016 | 138 | 0.050 |
Why?
|
Epoxide Hydrolases | 1 | 2020 | 9 | 0.050 |
Why?
|
Visual Cortex | 1 | 2000 | 8 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2020 | 25 | 0.050 |
Why?
|
Molecular Chaperones | 1 | 2020 | 12 | 0.050 |
Why?
|
Auditory Cortex | 1 | 2000 | 4 | 0.050 |
Why?
|
Mortality | 1 | 2021 | 86 | 0.050 |
Why?
|
Databases as Topic | 1 | 2000 | 19 | 0.050 |
Why?
|
Executive Function | 1 | 2021 | 121 | 0.050 |
Why?
|
Motor Cortex | 1 | 2000 | 17 | 0.050 |
Why?
|
Models, Neurological | 1 | 2000 | 30 | 0.050 |
Why?
|
Hemodynamics | 1 | 2000 | 83 | 0.050 |
Why?
|
Blood Pressure | 1 | 2022 | 238 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 55 | 0.050 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2020 | 42 | 0.050 |
Why?
|
Research | 1 | 2000 | 54 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 75 | 0.050 |
Why?
|
Heredity | 1 | 2019 | 6 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 32 | 0.040 |
Why?
|
Nestin | 1 | 2019 | 3 | 0.040 |
Why?
|
United Kingdom | 1 | 2019 | 50 | 0.040 |
Why?
|
SOXB1 Transcription Factors | 1 | 2019 | 4 | 0.040 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2019 | 9 | 0.040 |
Why?
|
Research Design | 1 | 2021 | 212 | 0.040 |
Why?
|
Neurogenesis | 1 | 2019 | 13 | 0.040 |
Why?
|
SNARE Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
Accelerometry | 1 | 2019 | 87 | 0.040 |
Why?
|
Diagnosis | 1 | 2018 | 23 | 0.040 |
Why?
|
Entorhinal Cortex | 1 | 2019 | 37 | 0.040 |
Why?
|
Demography | 1 | 2018 | 77 | 0.040 |
Why?
|
Chicago | 1 | 2021 | 865 | 0.040 |
Why?
|
Protein-Arginine Deiminases | 1 | 2017 | 11 | 0.040 |
Why?
|
alpha-Macroglobulins | 1 | 2017 | 12 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 42 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 37 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2019 | 676 | 0.040 |
Why?
|
Netrin Receptors | 1 | 2017 | 5 | 0.040 |
Why?
|
Linkage Disequilibrium | 1 | 2017 | 47 | 0.040 |
Why?
|
RNA | 1 | 2017 | 39 | 0.040 |
Why?
|
Methionine Sulfoxide Reductases | 1 | 2017 | 5 | 0.040 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2017 | 7 | 0.040 |
Why?
|
Oncogene Protein v-akt | 1 | 2016 | 12 | 0.040 |
Why?
|
Lumbar Vertebrae | 1 | 2002 | 487 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 74 | 0.040 |
Why?
|
Glycoproteins | 1 | 2017 | 58 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 48 | 0.040 |
Why?
|
Borderline Personality Disorder | 1 | 2016 | 4 | 0.040 |
Why?
|
Vulnerable Populations | 1 | 2016 | 24 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 389 | 0.040 |
Why?
|
Arterial Pressure | 1 | 2016 | 14 | 0.030 |
Why?
|
Personality | 1 | 2016 | 68 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 125 | 0.030 |
Why?
|
Sialic Acid Binding Ig-like Lectin 3 | 1 | 2015 | 15 | 0.030 |
Why?
|
Healthy Volunteers | 1 | 2015 | 46 | 0.030 |
Why?
|
Animals | 2 | 2019 | 4552 | 0.030 |
Why?
|
Risk | 1 | 2015 | 217 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2019 | 1830 | 0.030 |
Why?
|
Decision Making | 1 | 2016 | 220 | 0.030 |
Why?
|
Logistic Models | 1 | 2015 | 407 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 42 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2015 | 230 | 0.030 |
Why?
|
Surveys and Questionnaires | 1 | 2018 | 1184 | 0.030 |
Why?
|
Sleep | 1 | 2016 | 313 | 0.030 |
Why?
|
Child | 1 | 2017 | 1346 | 0.030 |
Why?
|
Sample Size | 1 | 2012 | 25 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 41 | 0.030 |
Why?
|
Genetic Markers | 1 | 2012 | 58 | 0.030 |
Why?
|
Games, Experimental | 1 | 2011 | 9 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2011 | 113 | 0.030 |
Why?
|
Mental Status Schedule | 1 | 2011 | 113 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2019 | 3273 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2007 | 26 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2016 | 1164 | 0.020 |
Why?
|
S100 Proteins | 1 | 2004 | 5 | 0.020 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2004 | 12 | 0.020 |
Why?
|
Glasgow Coma Scale | 1 | 2004 | 12 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2004 | 56 | 0.020 |
Why?
|
Echo-Planar Imaging | 1 | 2002 | 3 | 0.010 |
Why?
|
Rotation | 1 | 2002 | 142 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2002 | 52 | 0.010 |
Why?
|
Infant | 1 | 2003 | 531 | 0.010 |
Why?
|
Rest | 1 | 2001 | 32 | 0.010 |
Why?
|
Spine | 1 | 2002 | 121 | 0.010 |
Why?
|
Mental Processes | 1 | 2000 | 18 | 0.010 |
Why?
|
Intervertebral Disc | 1 | 2002 | 212 | 0.010 |
Why?
|
Biomechanical Phenomena | 1 | 2002 | 668 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2003 | 770 | 0.010 |
Why?
|